Menu

How Preston scientists have helped with prostate cancer breakthrough

Posted on - 13th April, 2016 - 7:00pm | Author - | Posted in - Business, News
Left to right - Kevin Vardy, Cambridge Oncometrix chief scientist Dmitry Soloviev, Cambridge Oncometrix CEO Maxim Rossmann, UCLan biomedical masters student Joe Mather and Dr Carole Rolph, senior lecturer in Clinical Biochemistry.

Left to right – Kevin Vardy, Cambridge Oncometrix chief scientist Dmitry Soloviev, Cambridge Oncometrix CEO Maxim Rossmann, UCLan biomedical masters student Joe Mather and Dr Carole Rolph, senior lecturer in Clinical Biochemistry.

Preston scientists have helped to develop an early test for prostate cancer.

Advertisement

Researchers at the University of Central Lancashire have worked with a medical research company on the breakthrough to speed up screening for the disease.

Senior lecturer in clinical biochemistry Dr Carole Rolph said: “This is an exciting collaboration that genuinely has the potential to save lives.

“Cambridge Oncometrix is on the verge of developing a piece of kit that will dramatically speed up the diagnosis process for prostate cancer.

“Here at UCLan we are delighted to play our part by working with Lancashire’s hospitals who will provide clinical samples for us to test substances, known as biomarkers, which are present in the fluids derived from the prostate gland and change when it becomes cancerous.”

One in eight men in the UK will get prostate cancer and in the majority of cases it can be cured if caught in time.

Kevin Vardy, a terminal prostate cancer sufferer whose online campaign to introduce a national prostate screening programme attracted more than 50,000 signatures, has backed the research and is already working with UCLan pharmacy and biomedical sciences students through the University’s Comensus project which links services users with those training to work in health and social care.

Related: Watch Preston university uses 3D printer to print medicine capsule

The 53-year-old said: “Had this type of screening been around three years ago my cancer may have been treatable so anything that speeds up and simplifies the diagnosis process can only be positive.

“It’s great news that UCLan is helping Cambridge Oncometrix advance this technology; more than 40,000 men are diagnosed with prostate cancer every year and 11,000 will die from it so we need to bring this potentially life-saving research under the spotlight.”

Cambridge Oncometrix CEO Maxim Rossmann said: “Our long-term goal is to make our product widely available through the NHS and to do this it has to undergo an intense period of testing. Both UCLan and some of the hospitals in Lancashire will play a key role in this process. Most men go to the doctors with prostate problems when it’s too late and our simple accurate test can help to solve this problem.”

Worried about prostate cancer? You can get support and advice from Prostate Cancer UK

Share
Preston in pictures The Old Black Bull Preston85mm f1.8 Ai Nikkor Delta 100SceneSnowy scenic in PrestonFeeding the freezing ducksDean's in PrestonRecently de-pedestrianised !!!On the bus View more Advertisement Subscribe to the newsletter

Sign up below to receive Blog Preston's weekly newsletter. It wings its way into inboxes every Sunday rounding up our best content from the last week and a look ahead to what's happening.

Advertisement News by location

Find news by location, select an area of your choice to be kept up to date with the latest goings on.

Advertisement Categories

Find news by category, select an category of your choice to be kept up to date with the latest goings on.